Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

UK Epilepsy Surgery Market

ID: MRFR/HC/51350-HCR
200 Pages
Rahul Gotadki
Last Updated: February 06, 2026

UK Epilepsy Surgery Market Research Report By Procedure Type (Respective Surgery, Laser Interstitial Thermal Therapy (LITT)) and By End User (Hospitals & Clinics, Specialty Centers) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

UK Epilepsy Surgery Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Surgical Procedure Type (USD Million)
  49.     4.1.1 Resective Surgery
  50.     4.1.2 Functional Surgery
  51.     4.1.3 Laser Surgery
  52.     4.1.4 Hemispherectomy
  53.   4.2 Healthcare, BY Indication (USD Million)
  54.     4.2.1 Drug-Resistant Epilepsy
  55.     4.2.2 Focal Epilepsy
  56.     4.2.3 Generalized Epilepsy
  57.     4.2.4 Neurodegenerative Disorders
  58.   4.3 Healthcare, BY Patient Demographics (USD Million)
  59.     4.3.1 Pediatric Patients
  60.     4.3.2 Adult Patients
  61.     4.3.3 Geriatric Patients
  62.   4.4 Healthcare, BY Technology (USD Million)
  63.     4.4.1 Neurostimulation Devices
  64.     4.4.2 Surgical Navigation Systems
  65.     4.4.3 Imaging Techniques
  66.     4.4.4 Robotic Surgery
  67.   4.5 Healthcare, BY Healthcare Setting (USD Million)
  68.     4.5.1 Hospitals
  69.     4.5.2 Specialized Epilepsy Centers
  70.     4.5.3 Outpatient Clinics
  71. 5 SECTION V: COMPETITIVE ANALYSIS
  72.   5.1 Competitive Landscape
  73.     5.1.1 Overview
  74.     5.1.2 Competitive Analysis
  75.     5.1.3 Market share Analysis
  76.     5.1.4 Major Growth Strategy in the Healthcare
  77.     5.1.5 Competitive Benchmarking
  78.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  79.     5.1.7 Key developments and growth strategies
  80.       5.1.7.1 New Product Launch/Service Deployment
  81.       5.1.7.2 Merger & Acquisitions
  82.       5.1.7.3 Joint Ventures
  83.     5.1.8 Major Players Financial Matrix
  84.       5.1.8.1 Sales and Operating Income
  85.       5.1.8.2 Major Players R&D Expenditure. 2023
  86.   5.2 Company Profiles
  87.     5.2.1 Medtronic (GB)
  88.       5.2.1.1 Financial Overview
  89.       5.2.1.2 Products Offered
  90.       5.2.1.3 Key Developments
  91.       5.2.1.4 SWOT Analysis
  92.       5.2.1.5 Key Strategies
  93.     5.2.2 Boston Scientific (GB)
  94.       5.2.2.1 Financial Overview
  95.       5.2.2.2 Products Offered
  96.       5.2.2.3 Key Developments
  97.       5.2.2.4 SWOT Analysis
  98.       5.2.2.5 Key Strategies
  99.     5.2.3 Abbott Laboratories (GB)
  100.       5.2.3.1 Financial Overview
  101.       5.2.3.2 Products Offered
  102.       5.2.3.3 Key Developments
  103.       5.2.3.4 SWOT Analysis
  104.       5.2.3.5 Key Strategies
  105.     5.2.4 NeuroPace (GB)
  106.       5.2.4.1 Financial Overview
  107.       5.2.4.2 Products Offered
  108.       5.2.4.3 Key Developments
  109.       5.2.4.4 SWOT Analysis
  110.       5.2.4.5 Key Strategies
  111.     5.2.5 Stryker (GB)
  112.       5.2.5.1 Financial Overview
  113.       5.2.5.2 Products Offered
  114.       5.2.5.3 Key Developments
  115.       5.2.5.4 SWOT Analysis
  116.       5.2.5.5 Key Strategies
  117.     5.2.6 Johnson & Johnson (GB)
  118.       5.2.6.1 Financial Overview
  119.       5.2.6.2 Products Offered
  120.       5.2.6.3 Key Developments
  121.       5.2.6.4 SWOT Analysis
  122.       5.2.6.5 Key Strategies
  123.     5.2.7 LivaNova (GB)
  124.       5.2.7.1 Financial Overview
  125.       5.2.7.2 Products Offered
  126.       5.2.7.3 Key Developments
  127.       5.2.7.4 SWOT Analysis
  128.       5.2.7.5 Key Strategies
  129.     5.2.8 Cleveland Clinic (GB)
  130.       5.2.8.1 Financial Overview
  131.       5.2.8.2 Products Offered
  132.       5.2.8.3 Key Developments
  133.       5.2.8.4 SWOT Analysis
  134.       5.2.8.5 Key Strategies
  135.     5.2.9 Epilepsy Society (GB)
  136.       5.2.9.1 Financial Overview
  137.       5.2.9.2 Products Offered
  138.       5.2.9.3 Key Developments
  139.       5.2.9.4 SWOT Analysis
  140.       5.2.9.5 Key Strategies
  141.   5.3 Appendix
  142.     5.3.1 References
  143.     5.3.2 Related Reports
  144. 6 LIST OF FIGURES
  145.   6.1 MARKET SYNOPSIS
  146.   6.2 UK MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE
  147.   6.3 UK MARKET ANALYSIS BY INDICATION
  148.   6.4 UK MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
  149.   6.5 UK MARKET ANALYSIS BY TECHNOLOGY
  150.   6.6 UK MARKET ANALYSIS BY HEALTHCARE SETTING
  151.   6.7 KEY BUYING CRITERIA OF HEALTHCARE
  152.   6.8 RESEARCH PROCESS OF MRFR
  153.   6.9 DRO ANALYSIS OF HEALTHCARE
  154.   6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  155.   6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  156.   6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
  157.   6.13 HEALTHCARE, BY SURGICAL PROCEDURE TYPE, 2024 (% SHARE)
  158.   6.14 HEALTHCARE, BY SURGICAL PROCEDURE TYPE, 2024 TO 2035 (USD Million)
  159.   6.15 HEALTHCARE, BY INDICATION, 2024 (% SHARE)
  160.   6.16 HEALTHCARE, BY INDICATION, 2024 TO 2035 (USD Million)
  161.   6.17 HEALTHCARE, BY PATIENT DEMOGRAPHICS, 2024 (% SHARE)
  162.   6.18 HEALTHCARE, BY PATIENT DEMOGRAPHICS, 2024 TO 2035 (USD Million)
  163.   6.19 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
  164.   6.20 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
  165.   6.21 HEALTHCARE, BY HEALTHCARE SETTING, 2024 (% SHARE)
  166.   6.22 HEALTHCARE, BY HEALTHCARE SETTING, 2024 TO 2035 (USD Million)
  167.   6.23 BENCHMARKING OF MAJOR COMPETITORS
  168. 7 LIST OF TABLES
  169.   7.1 LIST OF ASSUMPTIONS
  170.     7.1.1
  171.   7.2 UK MARKET SIZE ESTIMATES; FORECAST
  172.     7.2.1 BY SURGICAL PROCEDURE TYPE, 2026-2035 (USD Million)
  173.     7.2.2 BY INDICATION, 2026-2035 (USD Million)
  174.     7.2.3 BY PATIENT DEMOGRAPHICS, 2026-2035 (USD Million)
  175.     7.2.4 BY TECHNOLOGY, 2026-2035 (USD Million)
  176.     7.2.5 BY HEALTHCARE SETTING, 2026-2035 (USD Million)
  177.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  178.     7.3.1
  179.   7.4 ACQUISITION/PARTNERSHIP
  180.     7.4.1

UK Healthcare Market Segmentation

Healthcare By Surgical Procedure Type (USD Million, 2026-2035)

  • Resective Surgery
  • Functional Surgery
  • Laser Surgery
  • Hemispherectomy

Healthcare By Indication (USD Million, 2026-2035)

  • Drug-Resistant Epilepsy
  • Focal Epilepsy
  • Generalized Epilepsy
  • Neurodegenerative Disorders

Healthcare By Patient Demographics (USD Million, 2026-2035)

  • Pediatric Patients
  • Adult Patients
  • Geriatric Patients

Healthcare By Technology (USD Million, 2026-2035)

  • Neurostimulation Devices
  • Surgical Navigation Systems
  • Imaging Techniques
  • Robotic Surgery

Healthcare By Healthcare Setting (USD Million, 2026-2035)

  • Hospitals
  • Specialized Epilepsy Centers
  • Outpatient Clinics

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓